Servier Pharmaceuticals

Oncaspar

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Servier Pharmaceuticals

Oncaspar HCPCS:

J9266

HCPCS Code Descriptor:

Injection, pegaspargase, per single dose vial

Category:

J Code

Oncaspar NDCs:

72694-0954-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Injection

Oncaspar CPT Codes:

Some of the most common CPT administration codes for 'buy and bill' drugs can be found at the following link:

Potential NDC Listing Errors:

We have not identified any potential errors with the NDCs mapped to this HCPCS code.

About Oncaspar:

Oncaspar is an Oncology drug manufactured by Servier Pharmaceuticals and administered via the Injection route of administration. The J Code: J9266 is aligned to the drug Oncaspar.

ACCESS PRICING AND MORE BY REGISTERING

J9266 Added Date:

January 1, 1996

J9266 Effective Date:

January 1, 2009

J9266 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Oncaspar billing and coding information.
Oncaspar patient assistance information can be found through ServierOne at the URL: https://www.servierone.com/s/patient
Oncaspar prescribing information can be found at the link below:
Information regarding Oncaspar’s side effects can be found at MedlinePlus